Efficacy of Metabolically Supported Chemotherapy... (2017 study) Skip to main content
Case Study Cureus 2017

Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer.

İyikesici MS, Slocum AK, Slocum A, Berkarda FB, Kalamian M, Seyfried TN, Cureus, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers described the case of one 29-year-old woman with stage IV triple-negative breast cancer who received chemotherapy supported by metabolic therapy, a ketogenic diet, hyperthermia, and hyperbaric oxygen therapy.

What They Found

This single case report described a complete clinical, radiological, and pathological response in a woman with stage IV triple-negative breast cancer after six months of a combined treatment protocol. Before treatment, a PET-CT scan showed a 77 mm x 55 mm tumor in the left breast, multiple lymph nodes, and multiple liver masses. A follow-up PET-CT in February 2017 showed a complete therapeutic response with no abnormal FDG uptake. After a mastectomy in April 2017, the pathology also showed a complete response, matching the imaging.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a report of one patient with no comparison group, and the treatments were combined, so the effect of hyperbaric oxygen therapy alone cannot be separated from the others.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Study
Category Aging & Longevity
Source Pubmed
PubMed ID 28924531
Year Published 2017
Journal Cureus

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology